ArticleOncotarget2019

A high-throughput screen of pharmacologically active compounds for inhibitors of UHRF1 reveals epigenetic activity of anthracycline derivative chemotherapeutic drugs.

Hugh Giovinazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.